Skip to content
OpenCapital
Get started

Generate Biomedicines, Inc. GENB EBITDA margin

Other financials

Income statement

See full
Revenue$7.2M-18.1%
Operating income-$64.1M-33.1%
Net income-$61.4M-47.4%
EPS (diluted)-$1.07+34.0%

Balance sheet

See full
Cash & equivalents$160.6M-27.2%
Total debt$65.6M—
Total equity$514.8M+209%
Total assets$625.7M—

Cash flow

See full
Operating cash flow-$80.4M-51.2%
CapEx$3.8M+403%
Free cash flow-$84.2M-56.1%

Valuation

See full
Market cap$1.86B—
Enterprise value$1.76B—

Returns & leverage

See full
Debt / equity0.1×—
Current ratio9.2×—